(Last updated : 2025-03-03 12:01:10)
  HIGUCHI Tomoaki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Internal Medicine, Division of Rheumatology
   Position   Endowed Assistant Professor
■ Published papers
1. Case report  A case of gastric/duodenal diffuse large B cell lymphoma observed during the administration of tacrolimus/azathioprine for dermatomyositis 2025/02
2. Original article  Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study 2023/11/20
3. Original article  Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model 2023/11/08
4. Original article  Evaluation of RABBIT risk score in Japanese patients with rheumatoid arthritis starting first bDMARDs: a validation study using the IORRA cohort data. 2023/07/06
5. Original article  Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria. 2023/06/03
Display all(24)
■ Academic conference presentation
1. Causes and risk factors for death in Japanese systemic sclerosis  2024/03/14
2. Autoimmunity(FOXM1 regulates fibrotic activity of skin fibroblasts derived from patients with systemic sclerosis)  2022/11
3. Association study of IFIH1 gene polymorphisms in systemic sclerosis (SSc)  2022/04/25
4. MPO-ANCA POSITIVITY IS RELATED TO INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS  2018/06/15
5. Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis  2016/11/16
Display all(13)
■ Education
1. 2013/04~2017/03 〔Doctoral course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,